[Form 4] Sera Prognostics, Inc. Insider Trading Activity
Rhea-AI Filing Summary
Sera Prognostics director Sandra AJ Lawrence reported the sale of 3,899 shares of Class A common stock on 09/09/2025 under a Rule 10b5-1 trading plan adopted June 10, 2025. The shares were sold in multiple transactions at prices ranging from $2.99 to $3.12, with a reported weighted-average price of $3.05. After the reported dispositions, the reporting person beneficially owns 18,814 shares. The Form 4 was signed by an attorney-in-fact, Benjamin G. Jackson.
Positive
- None.
Negative
- None.
Insights
TL;DR: Director sold a small block under a pre-established 10b5-1 plan; procedural disclosure appears complete and routine.
The sale of 3,899 shares was executed pursuant to a Rule 10b5-1 plan adopted June 10, 2025, which indicates the transactions were pre-authorized. The filer remains a director and retains 18,814 shares after the sale. The Form 4 discloses the weighted-average sale price and the price range for the multiple transactions, and the filing includes an attorney-in-fact signature. There are no indications of undisclosed related-party transactions or departures from standard Section 16 reporting protocols in the document provided.
TL;DR: Transaction is a routine insider sale under a 10b5-1 plan; no new material operational or financial information disclosed.
The reported disposition reduces the reporting person's stake to 18,814 shares; the sale prices ranged from $2.99 to $3.12 with a weighted average of $3.05. The filing does not include any derivative transactions or additional material disclosures about the issuer's performance. From a market-impact perspective, the disclosed sale size and details suggest a routine liquidity event rather than a material corporate development.